Newsroom

OnQuality Pharmaceuticals Announces Completion of Part 1 of NOVA-II Trial

- Top-line readout of clinical study results anticipated by the end of 2021 SEATTLE, Sept. 7, 2021 /PRNewswire/ -- OnQuality...

SEATTLE, June 9, 2021 /PRNewswire/ -- OnQuality Pharmaceuticals ("OnQuality"), a targeted cancer supportive care company developing...

OnQuality Pharmaceuticals to Present on NOVA-II Trial Evaluating OQL011 at the 2021 ASCO and MASCC/ISOO Annual Meetings SEATTLE, May 19,...

SEATTLE and SHANGHAI—March 31, 2021. OnQuality Pharmaceuticals LLC ("OnQuality"), a targeted cancer supportive care company developing me...

Seattle, WA—August 14, 2020. OnQuality Pharmaceuticals (USA) LLC, dedicated to the discovery and development of therapies to improve qua...

Shanghai, China—Oct. 28th, 2019. OnQuality Pharmaceuticals Ltd., a start-up pharmaceutical company focusing on mitigating on-target toxic...

Shanghai, China—May 24th, 2019. OnQuality Pharmaceuticals Ltd., today announced the U.S. Food and Drug Administration (FDA) clearance of...